KAYA Kaya Q4 FY25 results (Jan–Mar 2025) and concall
Kaya Limited reported a 15% collection growth in its India clinics for Q4 FY25, driven by strong performance in services like Anti-Ageing (40% growth) and Body contouring (38% growth). Revenue from operations increased 3% YoY to INR 54.7 crores, though the company posted a standalone loss after tax of INR 7.1 crores. Management outlined plans for a rights issue to retire debt and accelerate expansion, with 7 new clinics already signed for FY26, aiming for net worth positivity and improved profitability.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 52 | 58 | 55 |
| EBITDA | 6 | 1 | 6 |
| Net profit | -11 | -15 | -7 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
